Evaluation of novel influenza A viruses and their pandemic potential

The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.

Vaccine·2026

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

Vaccine·2026

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

The Journal of infection·2024

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

The Journal of infection·2024

Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.

Journal of virological methods·2024

A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Nature cell biology·2023

Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management.

Pediatric annals·2026

Pediatric Nonmalignant Hematopoietic Cell Transplantation in the Era of Precision Conditioning and Gene Therapy.

Pediatric annals·2026

Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis.

Pediatric annals·2026

Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation.

Pediatric annals·2026

Hemoglobinopathies and Cellular Therapy: What Pediatricians Need to Know About Indications and Counseling.

Pediatric annals·2026

Structured Approach to Pediatric Acute Gastroenteritis: Discussion of Diagnostics and Treatment of Acute Gastroenteritis in Children.

Pediatric annals·2026

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Bioinformatics (Oxford, England)·2026

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

Experimental lung research·2026

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Allergy·2026

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

Human vaccines & immunotherapeutics·2026

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

International journal of molecular medicine·2026

Organelle-centered ISG15 biology: distinguishing covalent ISGylation from interferon-associated responses.

Frontiers in immunology·2026

Related Experiment Videos

Evaluation of novel influenza A viruses and their pandemic potential

Related Concept Videos

The platform trial in COVID-19 priming and BOOsting (PICOBOO): The reactogenicity of nine licensed COVID-19 vaccines delivered in immunocompetent adults.

The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.

The Platform Trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of licensed COVID-19 vaccinations administered as a second booster in BNT162b2 primed individuals aged 18-<50 and 50-<70 years old.

The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.

Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.

A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts.

Inborn Errors of Immunity and Hematopoietic Cell Transplantation: Recognition and Pretransplant Management.

Pediatric Nonmalignant Hematopoietic Cell Transplantation in the Era of Precision Conditioning and Gene Therapy.

Recognition and Management of Ulcerative Infantile Hemangioma: Risk Factors, Diagnosis, and Prognosis.

Shared Care After Pediatric Nonmalignant Hematopoietic Cell Transplantation.

Hemoglobinopathies and Cellular Therapy: What Pediatricians Need to Know About Indications and Counseling.

Structured Approach to Pediatric Acute Gastroenteritis: Discussion of Diagnostics and Treatment of Acute Gastroenteritis in Children.

VirPLM: Antigenic prediction of influenza A/H3N2 viruses with a fine-tuned protein language model.

Mechanism of IH promoting pulmonary arterial hypertension through ROS-NLRP3 inflammasome mediated endothelial cell pyroptosis.

IgE-Binding Bacterial Components Not Yet Documented in the Allergen Databases and Their Allergenic Mechanisms: An EAACI Position Paper.

Multifocal mucocutaneous herpes simplex virus type 1 infection temporally associated with seasonal influenza vaccination in a young adult without a known immunocompromising condition: A case report.

ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review).

Organelle-centered ISG15 biology: distinguishing covalent ISGylation from interferon-associated responses.

Related Experiment Videos

Evaluation of novel influenza A viruses and their pandemic potential

Related Concept Videos

Related Articles